Literature DB >> 31686155

Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis.

Philipp Riffel1, Mohamad Jawhar2, Kristina Gawlik3, Juliana Schwaab3, Henrik J Michaely4, Georgia Metzgeroth3, Wolf-Karsten Hofmann3, Stefan O Schoenberg1, Andreas Reiter3.   

Abstract

Systemic mastocytosis (SM) is broadly subcategorized according to mast cell (MC) burden and organ involvement into indolent (ISM), smoldering (SSM), and advanced SM (AdvSM). However, the pattern and extent of bone involvement remains controversial. In this institutional review board (IRB)-approved study, 115 patients with different forms of SM (ISM (n = 37, 32%), SSM (n = 9, 8%), and AdvSM (n = 69, 60%)) underwent a whole-body magnetic resonance imaging including sagittal and coronal T1 and turbo inversion recovery magnitude (TIRM) sequences of the spine. The evaluation included the pattern and extent of pathologic bone marrow (BM) signals in the spine and extremities, osteolytic lesions, and vertebral fractures. A pathologic BM pattern was observed in 4/37 (11%), 8/9 (89%), and 66/69 (96%); affection of the appendicular skeleton in 3/37 (8%), 8/9 (89%), and 67/69 (97%); and vertebral fractures in 7/37 (19%), 0/9, and 13/69 (19%) patients with ISM, SSM, and AdvSM, respectively. In AdvSM, pathologic BM pattern included activated (62%), diffuse sclerotic (25%), and small-spotted BM (9%), respectively. Only activated/sclerotic BM was associated with significantly higher MC burden, organ damage, and inferior median survival (2.9 years, p = 0.04). Vertebral fractures resembled classical multi-segmental osteoporotic fractures in ISM but not in AdvSM in which they were only found in activated/sclerotic BM. Only one patient with AdvSM had a focal osteolytic lesion in the femur. Activated/sclerotic BM changes of the spine and affection of the appendicular skeleton are indicative for SSM or AdvSM. Osteolytic lesions, which are very rare, and osteoporotic fractures are ineligible for the diagnosis of AdvSM.

Entities:  

Keywords:  Bone marrow; Magnetic resonance imaging; Osteolytic lesions; Osteoporosis; Systemic mastocytosis

Mesh:

Year:  2019        PMID: 31686155     DOI: 10.1007/s00277-019-03826-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  3 in total

Review 1.  Systemic mastocytosis revisited with an emphasis on skeletal manifestations.

Authors:  Antonio Leone; Marianna Criscuolo; Consolato Gullì; Antonella Petrosino; Nicola Carlo Bianco; Cesare Colosimo
Journal:  Radiol Med       Date:  2020-11-26       Impact factor: 3.469

Review 2.  Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Ivan Alvarez-Twose; Knut Brockow; Olivier Hermine; Marek Niedoszytko; Juliana Schwaab; Jonathan J Lyons; Melody C Carter; Hanneke Oude Elberink; Joseph H Butterfield; Tracy I George; Georg Greiner; Celalettin Ustun; Patrizia Bonadonna; Karl Sotlar; Gunnar Nilsson; Mohamad Jawhar; Frank Siebenhaar; Sigurd Broesby-Olsen; Selim Yavuz; Roberta Zanotti; Magdalena Lange; Boguslaw Nedoszytko; Gregor Hoermann; Mariana Castells; Deepti H Radia; Javier I Muñoz-Gonzalez; Wolfgang R Sperr; Massimo Triggiani; Hanneke C Kluin-Nelemans; Stephen J Galli; Lawrence B Schwartz; Andreas Reiter; Alberto Orfao; Jason Gotlib; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Hemasphere       Date:  2021-10-13

3.  Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis.

Authors:  Julia Riffel; Johannes Lübke; Andreas Reiter; Philipp Riffel; Nicole Naumann; Sebastian Kreil; Georgia Metzgeroth; Alice Fabarius; Karl Sotlar; Hans-Peter Horny; Mohamad Jawhar; Daniel Overhoff; Stefan Schoenberg; Wolf-Karsten Hofmann; Thomas Henzler; Juliana Schwaab
Journal:  Sci Rep       Date:  2022-08-20       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.